Newsletter

207940 - Samsung Biologics Co., Ltd.

207940 Summary
Biopharma
Stock Price & Overview
₩1,447,000 -30,000 (-2.03%) Close · Sep 4, 2026 KST
KOSPI | ₩KRW | Close: ₩1,447,000  ≈ US$1,034  ·  Market cap ₩67.0tn (≈ $47.8bn)
Home › 207940 › Filings

Preliminary Consolidated Results (Fair Disclosure)

DART
Samsung Biologics Co., Ltd.
Filed Jul 23, 2026 KST · Earnings · receipt 20260723800003

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 연결재무제표기준영업(잠정)실적(공정공시)

207940

Price
₩1,447,000
Change
-2.03%
Market cap
₩67.0tn
Prev. close
₩1,477,000
207940 SummaryCompare to Peers

More 207940 filings

Investor Relations Event

09/03/26

Acquisition of Shares in Another Company

08/31/26

Large business group status disclosure — quarterly, individual company

08/31/26

Investor Relations Event

08/28/26

Material event report (paid-in capital increase)

08/28/26

Record date set, shareholder register closed

08/28/26